MECHANISM OF ACTION
The Meno-Pause blend is a proprietary combination targeting the multiple axes affected in menopause: the HPG axis (kisspeptin component - GnRH pulse regulation), mood and anxiety pathways (selank/neuropeptide component - GABAergic and serotonergic modulation), and systemic repair/anti-ageing (likely BPC-157 or TB-500 component). Menopausal symptom research increasingly involves peptide approaches to address the hormonal disruption, cognitive fog, mood dysregulation, and musculoskeletal changes associated with declining oestrogen - without exogenous hormone replacement. The specific formulation is proprietary to the Peptide Pen brand.
RESEARCH APPLICATIONS
- Perimenopausal and menopausal symptom research
- HPG axis support (GnRH/LH pulsatility)
- Mood and anxiety modulation in hormonal transition
- Anti-ageing and recovery support for post-menopausal physiology
- Female HPG axis modulation in preclinical models
RESEARCH HIGHLIGHTS
Peptide Approach to Hormonal Transition
Kisspeptin, Selank, and recovery peptide components each have independent research support for their target axes - the combination addresses multiple menopausal symptom pathways simultaneously.
Ref: See individual compound pages for supporting research
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
2–8°C. Follow standard peptide storage - keep cold, protect from light, use reconstituted solution within 21 days.
Regulatory Status
Research compound. No regulatory approval. Not WADA prohibited. SA: unscheduled research compound.